Bain Capital Life Sciences Investors, LLC — 13F holdings

Bain Capital Life Sciences Investors, LLC reported 21 holdings worth $1.68B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. KLRA KAILERA THERAPEUTICS INC — $498M (29.6%)
2. HTFL HEARTFLOW INC — $248M (14.7%)
3. NAMS NEWAMSTERDAM PHARMA COMPANY — $129M (7.7%)
4. SVRA SAVARA INC — $108M (6.4%)
5. ALKS Alkermes PLC — $102M (6.0%)
6. SLDB SOLID BIOSCIENCES INC — $98.0M (5.8%)
7. PHVS PHARVARIS N V — $92.5M (5.5%)
8. OLMA OLEMA PHARMACEUTICALS INC — $88.6M (5.3%)
9. COAG HEMAB THERAPEUTICS HLDGS INC — $60.6M (3.6%)
10. CABA CABALETTA BIO INC — $53.6M (3.2%)